Conference Coverage
Conference Coverage
Drugs to prevent versus those to treat migraine might not share targets
The distinct molecular events in each phase of migraine suggest the prevention and treatment targets differ.
Conference Coverage
Adolescents with migraine need smooth handoff to adult care
One goal of migraine management in adolescents and young adults should be to prevent adulthood chronicity.
Conference Coverage
Avoid adding to minority stress when treating headache in LGBTQIA+ patients
To address headache in LBGTQIA+ patients, inclusive behavior can set the stage of collaboration toward control.
Conference Coverage
What is the proper treatment for posttraumatic headache? Expert debate
Preventative treatment could reduce chronification, but has the potential to worsen comorbidities.
Conference Coverage
Prodrome treatment with ubrogepant prevents migraines
Intervention also reduced prodromal symptoms in patients who could reliably predict oncoming headaches.
Conference Coverage
Migraine treatment with rimegepant linked to reduced barbiturate use
Real-world analysis suggests potential for improvements in medication overuse and dependency.
Conference Coverage
Anti-CGRP monoclonal antibody offers relief from migraine and comorbid depression
“If the patient has migraine and depression and you treat with fremanezumab, both disorders get better to a statistically significant degree.”
Conference Coverage
Can a puff of cool air up the nose stop acute migraine?
Most patients reported relief of their symptoms after receiving 15 minutes of transnasal evaporative cooling, without any need for rescue...
Conference Coverage
Migraine device expands treatment possibilities
New studies of remote electrical neuromodulation show efficacy in adolescents and safety during pregnancy.
Conference Coverage
Cannabis RCT shows efficacy, AEs in migraine
First RCT in migraine suggests THC/CBD mix might be best, and that recreational doses may be higher than necessary.